Spac
Never Come DownGoogle the 2016 Trump song...
Normally I discourage people from buying IPOs first day or first week. In this case I think it will be a fun ticket.
The key takeaway of 2021 markets are: more thinking = less gains
What is this you might ask?
Shares of Trump-linked SPAC close up 350% following news of social media deal
www.cnbc.com
$DKNG GETTING READY FOR A +40% MOVE!What Is the Accumulation Area?
The accumulation area on a price and volume chart is characterized by mostly sideways stock price movement, which is seen by investors or technical analysts as indicative of large institutional investors buying, or accumulating, a large number of shares over time.
Source: www.investopedia.com
1HR
- Price trading sideways since late September.
Analyst Price Target on $DKNG (TipRanks)
High: 105
Average: 70.06 (44.01% Upside)
Low: 41
Comparison charts: $HLBZ $IRNTHelbiz Inc. provides micro-mobility services. The company offers a fleet of vehicles, including e-scooters, e-bicycles, and e-mopeds all on one convenient platform in 35 cities worldwide. It utilizes a customized, proprietary fleet management platform, artificial intelligence, and environmental mapping to optimize operations and business sustainability. The company also focuses on expanding its urban lifestyle products and services to include live streaming services, food delivery, financial services, and others accessible within its mobile app. The company was incorporated in 2015 and is headquartered in New York, New York.
IronNet Cybersecurity, Inc. designs and develops solutions for cyber-attacks. It offers IronDefense, a network traffic analysis platform that delivers scalable behavioral analysis and integrated packet-level cyber hunt to detect advanced threats; and IronDome, a collective defense solution that delivers machine-speed visibility of potential threat campaigns targeting participant industry peers. The company also provides a suite of technologies that provide real-time threat assessment and updates, behavioral modeling, big data analytics, and proactive responses; and consulting and training programs to protect against current and emerging threats. Its security solutions include collective defense, network traffic analysis, and cyber assessment tools. The company serves energy and utilities, financial services, healthcare and life sciences, defense, and public sector industries. The company was incorporated in 2014 and is based in McLean, Virginia with additional offices in Raleigh, North Carolina; Fulton, Maryland; London, United Kingdom; and Singapore.
$SRZNCommon stock and warrants to commence trading on Nasdaq on August 12, 2021 under the ticker symbols SRZN and SRZNW
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen”), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today announced the completion of its business combination with Consonance-HFW Acquisition Corp. (“Consonance-HFW”), a special purpose acquisition company (“SPAC”) sponsored by entities affiliated with Consonance Capital Management. The resulting combined company will commence trading its shares on Nasdaq under the ticker symbol “SRZN” and its warrants under the ticker symbol “SRZNW” on August 12, 2021.
The shareholders of Consonance-HFW approved the transaction at an extraordinary general meeting held on August 10, 2021, and the transaction was previously approved by Surrozen’s stockholders. Surrozen’s management team, led by President and Chief Executive Officer, Craig Parker, will continue to lead the combined company.
Craig Parker, President and Chief Executive of Officer of Surrozen, commented, “We have long known the importance of the Wnt pathway as the body’s own mechanism for tissue repair but harnessing its promise for therapeutic applications remained out of reach for drug developers until recently. We believe Surrozen has the potential to unlock the promise of the Wnt pathway and transform treatment of multiple serious diseases.” He further commented, “The capital raised from the successful completion of this transaction, along with our strategy to accelerate the development of our innovative programs, will help us bring this vision to life.”
Gad Soffer, Chief Executive Officer of Consonance-HFW, commented, “We are proud to partner with Surrozen in hopes of providing breakthrough therapies in areas of high unmet need.” He added, “By combining experienced industry leaders with an innovative approach to harness the therapeutic potential of the Wnt pathway, we believe Surrozen is well positioned in its efforts to transform treatments for serious diseases.”
About this Transaction
On April 15th, 2021, Surrozen, a privately held biotechnology company, entered into a definitive business combination agreement with Consonance-HFW, a special purpose acquisition company (SPAC) that was created for the purpose of entering into a business combination with a selected life sciences company.
The description of the business combination contained herein is only a high-level summary and is qualified in its entirety by reference to the underlying documents filed with the U.S. Securities and Exchange Commission. A more detailed description of the terms of the transaction has been provided in a registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission by Consonance-HFW.
Transaction Advisors
J.P. Morgan Securities LLC is acting as financial advisor to Consonance-HFW in connection with the business combination, and J.P. Morgan Securities LLC and BofA Securities are acting as placement agents on behalf of Consonance-HFW. Guggenheim Securities, LLC is acting as financial advisor and capital markets advisor to Surrozen, and Stifel, Nicolaus & Company, Incorporated is acting as capital markets advisor to Surrozen in the transaction. Goodwin Procter LLP is acting as legal counsel to Consonance-HFW, Cooley LLP is acting as legal counsel to Surrozen and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal counsel to the placement agents.
About Consonance-HFW Acquisition Corp.
Consonance-HFW Acquisition Corp. is a recently incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. It is led by Chairman Mitchell Blutt, M.D., Chief Executive Officer Gad Soffer, Chief Financial Officer Kevin Livingston and VP Business Development Joshua House.
About Consonance Capital Management
Consonance Capital Management was founded in 2007 with approximately $50 million of assets under management by Mitchell Blutt, Benny Soffer and Kevin Livingston. As of March 31, 2021, the fund has grown to approximately $1 billion in assets under management and focuses on equity investments in life sciences companies, with an emphasis on small and mid-cap life sciences companies.
About Surrozen
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with potential application across multiple disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas and central nervous system.
Wyckoff Accumulation HYLN updated 8/19EV sector continues to show behind the scenes buying from HFs/tutes (look at unusualwhales.com and sort by date of 13F filing). in a previous post, i shared this idea and thought that the accumulation was happening without this downward move into a spring happening. clearly i was incorrect, as we saw very strange -4% days all in a row--which appears very "manipulated" when you also account for increased volume. (i hate using that term "manipulated" but what i mean is that the price was suppressed to allow for more accumulation by those who have the capital to do so).
QE2 results a catalyst to higher pricesMP has been doing well in the past weeks while the small-cap stocks market notably SPACs were beaten down to disappointing prices. Now that there is less than a week to the QE2 results the price is at a pivotal level. There are resistance levels around $39 and $41, which can be broken if $MP reports impressive results as they have done it after their SPAC merger in 2020. Chamath Palihapitiya was the PIPE investor of this stock and it seems it is one of his best so far. The other ones such as $OPEN $CLOV are not doing well. Even, $SOFI did not have a good performance as many of its holders expected. A market rotation to small/medium cap stocks can send many of these stocks to the sky again, but that is a big question for right now as the mega-cap stocks are the safe haven for the big dogs.
MATTERPORT IPO DEBUT w/ some TA on the 15 minute chartToday Matterport previously GHVI changed its ticker to MTTR and had a decent open with about 1.5 million volume up until it was debuted on CNBC by the anchor Josh Brown. Then we saw a huge pump up from that area and about 3-4 million volume traded after he said he wants to buy after earnings happen. He is bullish on Matterport but also wanted to wait for earnings to add. We have a few stages of the DE-SPAC process to go through here that can help a long term investor DOLLAR COST AVERAGE down.
Pipe dump, Warrant Redemption, Insider Lockup periods, and whatever else in relation to that process.
This made for decent long and short momentum plays today. A lot of swings came in hot on the CNBC news and sold off on the momentum and a lot of puts and shorts came in on that momentum to take over as the double top was confirmed. We saw the bulls and bears fighting at close to hold $15 which is broke to $14.96 end of day.
Was quite exciting to watch it all go down!
PENN Retesting $85 Soon?Penn National Gaming has quietly been gaining momentum during July after a massive fall in price since earlier this year. If we do a fib retracement from the swing high at $85 to its swing low at our bottom which is $63, we get a potential trade setup currently at the $71.84 price level. This $71 area is where the .382 fib level is, historically a great buy area mathematically speaking.
Depending on the open in the morning I plan on going long with a stop just below $71.84.
The key is that the $71.84 price holds. If a 4 hour candle closes below that, a retest of $68 will be in the cards which is my next and final buy area where a large position may be entered.
Major Reversal for Lordstown?Big things could be in store for RIDE after a brutal yet easily foreseen correction in price for the larger part of the year so far.
This asset has been a bucking bronco and now looks to be whipsawing inside of an ascending channel on the weekly and daily timeframes. There appears to be support just below $10 at the moment and should this level hold on the weekly, a spike to the .236 fib level could be in store at $12.64 - a whopping 37% move to the upside. That will be the first level to take profit. The top of the ascending channel would be the ultimate target which currently stands at roughly 70% to the upside from the current price as of writing this.
The opening of this short week on Tuesday will be telling as this is an asset that moves very quickly.
Take note of the RSI on the weekly as it is at a low risk area with plenty of room to run to the upside if it so chooses to. The same can be said of the daily RSI as well.
Lastly, a breaking of the green support line with a confirmed close on the weekly would suggest a return to the $6.72 low - 27% drop from where we currently stand.
This trade will require one's active and preferably professional attention due to the volatile nature of this asset's price action.
$WKHS PT 40-60 and higherWorkhorse Group Inc., a technology company, designs, manufactures, builds, and sells battery-electric vehicles and aircraft in the United States. The company also develops cloud-based and real-time telematics performance monitoring systems that enable fleet operators to optimize energy and route efficiency. It offers electric and range-extended medium-duty delivery trucks under the Workhorse brand; and HorseFly Unmanned Aerial System, a custom-designed purpose-built all-electric drone system. The company was formerly known as AMP Holding Inc. and changed its name to Workhorse Group Inc. in April 2015. Workhorse Group Inc. was founded in 2007 and is headquartered in Loveland, Ohio.
$CMLF Target PTs 35-40 and higherCM Life Sciences, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company focuses on targeting life science companies. CM Life Sciences, Inc. was incorporated in 2020 and is based in New York, New York.
$STIC can rise in the next daysContextual immersion trading strategy idea.
Northern Star Acquisition Corp. is gonna merge with Bark Box and become $BARK today. I saw a huge momentum on Friday.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $11.17;
stop-loss — $10.05.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
CCIV (SPAC for Lucid Motors) Looks Poised To Break Out ViolentlyAlthough it's possible that the Lucid merger could result in a common "buy the rumor, sell the news" scenario, given how beat up the stock has been in recent months, this scenario seems less likely. Furthermore, the coiling price action right next to a major resistance line in the past trading day suggests that bullish pressure is building.
$CLOV In Depth Analysis & Price PredictionsClover health has quite the catalysts not only fundamentally, but technically as well.
Technicals:
CLOV has been in a downtrend since early January, with an all time high near $17.00, and all time low of near $6.00. Quite the range. Fibonacci retracement levels can give us approximate levels of support and resistance once a breakout occurs. As you can see, the daily chart here shows a SLIGHT breakout (See B2) above the downtrend, as also seen in April (See B1). Another green candle above the downward trendline would give me further confidence of a breakout towards first $10.50, and then $11.86 following, the retracement levels act as price zones of support and resistance for my trading style.
More on technical setup, we have a nice MACD convergence on the 1D chart, forming a nice consolidation for a breakout within the MACD, where I see a bullish reversal that can last long term.
Fundamentals:
Not going to lecture you on the company, but rather give you some interesting catalysts and factors that will most definitely play into the price.
1. Short interest is over 50% of the float, which to me, gives a lot of potential for a true squeeze, higher than GME and AMC.
2. Because CLOV is a SPAC, insider shares have a lockup as well as a predetermined price that the stock MUST be trading at for 90 consecutive days before insiders can sell. that price is $30 a share. Meaning if they want to sell their shares, price has to be $30 for atleast 90 days.
3. Short positions are in trouble near the $11 level, meaning above $11, nearly 100% of all short positions are in the red, and losing money.
4. Shares available to be shorted as of yesterday was only 600,000.
With squeeze potential like this, such a large short percent of the float, and company insiders not being able to sell until $30 a share, expect nothing less of parabolic movement, but the real question is WHEN. Timing this will be a difficult thing to do, but I will be playing this with long term leap options as well as shares for accumulation.
GLTA, in Chamath we trust, I guess.
SOFI - This Is The BeginningHello everyone,
I hope you are doing fantastic.
We went through the SPAC merger with amazing volume and great price movement.
I would say that this is one of the best value plays at the moment and we got a rather cheap valuation of around 2.3B Market Cap for the stock, which gives us plenty of growth potential.
The company may very well be one of WSB's mentioned stock, so this may further drive the price up.
Also, it does have the potential to get on the ARK portfolio in the future, which would further increase the price.
The minimum price target on the stock is $50 in my opinion and I would say we should be there until the end of the year.
I see this as a pure long-term play and the price we are getting at is more than amazing.
I wish you good luck and stay green!
Velodyne Lidar Inc 🧙Velodyne Lidar Inc provides sensor technologies for autonomous vehicles. It provides lidar solutions for autonomous vehicles, driver assistance, delivery solutions, robotics, navigation, and mapping. The product portfolio includes surround sensors, directional sensors, close-range sensors, and other related software.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ACTC : COIL / POSITION TRADEArcLight (ACTC) is bringing Proterra to market at a reasonable valuation.
Proterra is a best in class commercial electric vehicle company with a solid offering, organization, and plan making it much more than an EV bus company.
Since its founding in 2004 and first bus delivery in 2009 Proterra has sold more than 1,000 EV buses in North America, the largest in region, and has a 50% market share.
The company has installed over 450 charge points. The plan is to be able to deliver peak power to handle hundreds of vehicles with fleet chargers some of which are capable of charging 40 buses at a time. The company is focused on building out fleet depots, en-route top up locations, and warehouse charging locations using existing infrastructure where possible.
Unlike many of their EV peers the price to sales ratio on any near term year is still fairly inexpensive at 13.8x compared to a lot higher levels from SPAC EVs of late.
Gross margins are expected to plateau around 25% which is likely to be more than attainable in our experience. They have a roadmap plotted to achieve this via scale and component improves by 2025 from current levels of 4%.
SOURCE : Steve Zachritz, Jan. 13, 2021, Seeking Alpha
seekingalpha.com
QS DADDY IS BACKSee you've grown up and learned to be a degenerate just like your pops. not bad.
Give your dad some smokes, it's story time.
QS is one of the biggest shitshows since that time your mother got kicked out of Kokomo's on that Havasu trip.
I know you just read the Intelligent Investor and want to force feed some fundamentals or facts about batteries to me. Save it kid.
your dad has $50 riding on this bad boy, and I'm not going to let you kill my vibes.
The past few months have been tormented by complex triangles and wave five compression.
We love to see it.
It's your time to shine.
Is this financial advice? Are you a motley fool? Will your mother ever be taken off Kokomo's black list?
leverage up cowboy. QS daddy going in.
oversold ESG play DNMR; go long. biodegradable plasticsThey are currently partnered with Pepsico and the University of Georgia working on fully biodegradable plastics; with Nestle and Walmart already signing on as customers. Got caught up in the SPAC sell-off. Doubtful it drops further so now would be a good time to initiate a long position. One strategy would be to buy half now than wait for a few trading sessions to see how it fares.
Oversold based on RSI with a bullish MACD cross on the horizon. Besides carbon emissions, plastics are another significant source of climate change and DNMR is a great way for fortune 500 companies to counteract their footprint and appease shareholders/board members on the ESG front.